Autism and vaccinations: The end?;Autismo y vacunas: ¿Punto final?

Revista de Neurologia

Volumn 50, Issue SUPPL. 3, 2010, Pages

  Artigas Pallarés, Josep ^a  

^a HOSPITAL DE SABADELL   (Spain)

Author keywords

Autism; Mercury; MMR; Thimerosal; Vaccinations

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; PRESERVATIVE; THIOMERSAL;

ARTICLE; AUTISM; COMPENSATION; COURT; HEARING; HUMAN; LAW SUIT; MEASLES; MUMPS; RUBELLA; SOCIAL ASPECT; TREATMENT RESPONSE; UNITED STATES; VACCINATION; COLITIS; CROHN DISEASE; INTERNATIONAL COOPERATION; REVIEW; RISK FACTOR;

AUTISTIC DISORDER; COLITIS; CROHN DISEASE; HUMANS; INTERNATIONAL AGENCIES; MEASLES-MUMPS-RUBELLA VACCINE; PRESERVATIVES, PHARMACEUTICAL; RISK FACTORS; THIMEROSAL;

EID: 77949539072     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Kanner L. Autistic disturbances of affective contact. Nerv Child 1943; 2: 217-50.
2. Bettelheim B. The empty fortress: infantile autism and the birth of the self. New York: Free Press; 1967.
3. Kanner L. Problems of nosology and psychodynamics in early childhood autism. Am J Orthopsychiatry 1949; 19: 416-26.
4. Chess SJ. Autism in children with congenital rubella. Autism Child Schizophr 1971; 1: 33-47.
5. Patterson PH. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 2008; 204: 313-21.
6. 6 on autistic children: a double-blind crossover study. Am J Psychiatry 1978; 135: 472-5.
7. Cornish E. Gluten and casein free diets in autism: a study of the effects on food choice and nutrition. J Hum Nutr Diet 2002; 15: 261-9.
8. Ashkenazi A, Levin S, Krasilowsky D. Gluten and autism. Lancet 1980; 19: 157.
9. Goodwin MS, Cowen MA, Goodwin TC. Malabsorption and cerebral dysfunction: a multivariate and comparative study of autistic children. J Autism Child Schizophr 1971; 1: 48-62.
10. Kahn AA. Thyroid dysfunction. Br Med J 1970; 21: 495.
11. Limperopoulos C, Bassan H, Sullivan NR, Soul JS, Robertson RL Jr, Moore M, et al. Positive screening for autism in ex-preterm infants: prevalence and risk factors. Pediatrics 2008; 121: 758-65.
12. Schendel D, Karapurkar Bhasin T. MPH birth weight and gestational age characteristics of children with autism, including a comparison with other developmental disabilities. Pediatrics 2008; 121: 1155-64.
13. Meyer U, Yee BK, Feldon J. The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? Neuroscientist 2007; 13: 241-56.
14. Braunschweig D, Ashwood P, Krakowiak P, HertzPicciotto I, Hansen R, Croen LA et al. Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology 2008; 29: 226-31.
15. Croen LA, Najjar DV, Fireman B, Grether JK. Maternal and paternal age and risk of autism spectrum disorders. Arch Pediatr Adolesc Med 2007; 161: 334-40.
16. Torres AR. Is fever suppression involved in the etiology of autism and neurodevelopmental disorders? BMC Pediatr 2003; 2: 3-9.
17. Grunes WF, Szyrynski VJ. Secondary pseudoautism caused by physiological isolation. Consult Psychol 1965; 29: 455-9.
18. Ornitz EM. Vestibular dysfunction in schizophrenia and childhood autism. Compr Psychiatry 1970; 11: 159-73.
19. Freedman DA. Congenital and perinatal sensory deprivation: some studies in early development. Am J Psychiatry 1971; 127: 1539-45.
20. Cohen DJ, Johnson WT, Caparulo BK. Pica and elevated blood lead level in autistic and atypical children. Am J Dis Child 1976; 130: 47-8.
21. Bernard S, Enayati A, Redwood L, Roger H, Binstock T. Autism: a novel form of mercury poisoning. Med Hypotheses 2001; 56: 462-7.
22. Boucher J. Hand preference in autistic children and their parents. J Autism Child Schizophr 1977; 7: 177-87.
23. Schinzel A. Fetal hydantoin syndrome in siblings. Schweiz Med Wochenschr 1979; 109: 68-72.
24. Thornton IM. Out of time: a possible link between mirror neurons, autism and electromagnetic radiation. Med Hypotheses 2006; 67: 378-82.
25. Gillberg C, Schaumann H. Epilepsy presenting as infantile autism? Two case studies. Neuropediatrics 1983; 14: 206-12.
26. Wakefield AJ, Pittilo RM, Sim R, Cosby SL, Stephenson JR, Dhillon AP, et al. Evidence of persistent measles virus infection in Crohn's disease. J Med Virol 1993; 39: 345-53.
27. Thompson NP, Montgomery SM, Pounder RE, Wakefield AJ. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 1995; 345: 1071-4.
28. Daszak P, Purcell M, Lewin J, Dhillon AP, Pounder RE, Wakefield AJ, et al. Detection and comparative analysis of persistent measles virus infection in Crohn's disease by immunogold electron microscopy. J Clin Pathol 1997; 50: 299-304.
29. Hermon-Taylor J, Ford J, Sumar N, Millar D, Doran T, Tizard M, et al. Measles virus and Crohn's disease. Lancet 1995; 345: 922-3.
30. Iizuka M, Saito H, Yukawa M, Itou H, Shirasaka T, Chiba M, et al. No evidence of persistent mumps virus infection in inflammatory bowel disease. Gut 2001; 48: 637-41.
31. Chadwick N, Bruce IJ, Schepelmann S, Pounder RE, Wakefield AJ. Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by the polymerase chain reaction. J Med Virol 1998; 55: 305-11.
32. Offit PA. Autism's false prophets. New York: Columbia University Press; 2008.
33. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 637-41.
34. Hauser KF, McLaughlin PJ, Zagon IS. Endogenous opioid systems and the regulation of dendritic growth and spine formation. J Comp Neurol 1989; 281: 13-22.
35. Sher L. Autistic disorder and the endogenous opioid system. Med Hypotheses 1997; 48: 413-4.
36. Reichelt KL. Gluten, milk proteins, and autism: results of dietary intervention on behavior and urinary peptide secretion. J Appl Nutr 1990; 42: 1-11.
37. Huebner FR, Lieberman KW, Rubino RP, Wall JS. Demonstration of high opioid-like activity in isolated peptides from wheat gluten hydrolysates. Peptides 1984; 5: 1139-47.
38. Uhlmann V, Martin CM, Sheils O, Pilkington L, Silva I, Killalea A, et al. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol 2002; 55: 84-90.
39. Allen A. The not so-crackpot autism theory. New York Times Magazine. November 10th 2002.
40. Geier MR, Geier DA. Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Exp Biol Med 2003; 228: 660-4.
41. Geier DA, Geier MR. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. Pediatr Rehabil 2003; 6: 97-102.
42. Brian Deer. URL: http://www.briandeer.com.
43. Murch SH, Anthony A, Casson DH, Malik M, Berelowitz M, Dhillon AP, et al. Retraction of an interpretation. Lancet 2004; 363: 750.
44. D'Souza Y, Fombonne E, Ward BJ. No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder. Pediatrics 2006; 118: 1664-75.
45. Afzal MA, Ozoemena LC, O'Hare A, Kidger KA, Bentley ML, Minor PD. Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK. J Med Virol 2006; 78: 623-30.
46. Baird G, Pickles A, Simonoff E, Charman T, Sullivan P, Chandler S, et al. Measles vaccination and antibody response in autism spectrum disorders. Arch Dis Child 2008; 93: 832-7.
47. Hornig M, Briese T, Buie T, Bauman ML, Lauwers G, Siemetzki U, et al. Lack of association between measles virus vaccine and autism with enteropathy: a case-control study. PloS One 2008; 3: 3140.
48. Goodman MJ, Nordin J. Vaccine adverse event reporting system reporting source: a possible source of bias in longitudinal studies. Pediatrics 2006; 117: 387-90.
49. Woo EJ, Ball R, Bostrom A, Shadomy SV, Ball LK, Evans G, et al. Vaccine risk perception among reporters of autism after vaccination: vaccine adverse event reporting system 1990-2001. Am J Public Health 2004; 94: 990-5.
50. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics. Ann Pharmacother 1999; 33: 1021.
51. Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 2007; 357: 1281-92.
52. Meilleur AA, Fombonne E. Regression of language and non-language skills in pervasive developmental disorders. J Intellect Disabil Res 2009; 53: 115-24.
53. Warkany J, Hubbard DM. Adverse mercurial reactions in the form of acrodynia and related conditions. Am J Dis Child 1951; 81: 335-73.
54. Kurland LT, Faro SN, Siedler H. Minamata disease. The outbreak of a neurologic disorder in Minamata, Japan, and its relationship to the ingestion of seafood contaminated by mercuric compounds. World Neurol 1960; 1: 370-95.
55. Nelson KB, Bauman ML. Thimerosal and autism? Pediatrics 2003; 111: 674-9.
56. Madsen KM, Lauritsen MB, Pedersen CB, Thorsen P, Plesner AM, Andersen PH, et al. Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics 2003; 112: 604-6.
57. Schechter R, Grether JK. Continuing increases in autism reported to California's developmental services system: mercury in retrograde. Arch Gen Psychiatry 2008; 65: 19-24.
58. Uchiyama T, Kurosawa M, Inaba Y. MMR-vaccine and regression in autism spectrum disorders: negative results presented from Japan. J Autism Dev Disord 2007; 37: 210-7.
59. Smeeth L, Cook C, Fombonne E, Heavey L, Rodrigues LC, Smith PG, et al. MMR vaccination and pervasive developmental disorders: a case-control study. Lancet 2004; 364: 963-9.
60. Fombonne E. Thimerosal disappears but autism remains. Arch Gen Psychiatry 2008; 65: 15-6.
61. Hertz-Picciotto I, Green PG, Delwiche L, Hansen R, Walker C, Pessah IN. Blood mercury concentrations in CHARGE study children with and without autism. Environ Health Perspect 2010; 118: 161-6.
62. Insciences Organisation. UC Davis study finds mercury levels in children with autism and those developing typically are the same. URL: http://insciences.org/article.php?article-id=7227.
63. Offit P. Thimerosal and vaccines: a cautionary tale. N Engl J Med 2007; 357: 1278-9.
64. Katz C. In big blow to parents of children with autism, court rules that vaccines are not to blame. Daily News. February 12th 2009.
65. URL: http://www.autism.uscfc.uscourts.gov/autism/vaccine/Hastings- Cedillo.pdf.
66. Institute of Medicine. Thimerosal-containing vaccines and neurodevelopmental disorders. Washington DC: National Academy Press; 2001.
67. URL: http://www.iom.edu/en/Reports/2003/Immunization-Safety-Review- Thimerosal-Containing-Vaccines-and-Neurodevelopmental-Disorders.aspx.
68. URL: http://www.who.int/vaccine-safety/topics/thiomersal/statement200308/ en/index.html.
69. URL: http://www.emea.eu.
70. Cox NH, Forsyth A. Thimerosal allergy and vaccination reactions. Contact Dermatitis 1988; 18: 22933.
71. URL: http://www.fda.gov/biologicsbloodvaccines/safetyavailability/ vaccinesafety.
72. URL: http://www.fda.gov/BiologicsBloodVaccines/vaccines/ QuestionsaboutVaccines.